FibroGen, Inc. (KYNB)
NASDAQ · Healthcare
FibroGen, Inc. Total Liabilities 2020–2025
FibroGen, Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- FibroGen, Inc. total liabilities as of December 31, 2025: 115.1M, a 71.09% decrease year-over-year.
- FibroGen, Inc. total liabilities for 2025 were 115.1M, a 71.09% decrease from 2024.
- FibroGen, Inc. total liabilities for 2024 were 398.2M, a 32.02% decrease from 2023.
- FibroGen, Inc. total liabilities for 2023 were 585.7M, a 4.23% decrease from 2022.
- FibroGen, Inc. total liabilities for 2022 were 611.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| FibroGen, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $115 |
| 2024 | $398 |
| 2023 | $586 |
| 2022 | $612 |
| 2021 | $545 |
| 2020 | $385 |
FibroGen, Inc. Total Liabilities — FAQ
FibroGen, Inc. (KYNB) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYNB's total liabilities history?
The chart and table above show FibroGen, Inc.'s total liabilities by year and by quarter, including the growth rate.